Literature DB >> 17170447

Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells.

Dupeh R Palmer1, Stefan Fernandez, John Bisbing, Kristina K Peachman, Mangala Rao, Dave Barvir, Vicky Gunther, Timothy Burgess, Yukari Kohno, R Padmanabhan, Wellington Sun.   

Abstract

The yellow fever virus attenuated 17D vaccine strain is a safe and effective vaccine and a valuable model system for evaluating immune responses against attenuated viral variants. This study compared the in vitro interactions of the commercially available yellow fever vaccine (YF-VAX), Dengue virus and the live-attenuated dengue vaccine PDK50 with dendritic cells (DCs), the main antigen-presenting cells at the initiation of immune responses. Similar to PDK50, infection with YF-VAX generated activated DCs; however, for YF-VAX, activation occurred with limited intracellular virus replication. The majority of internalized virus co-localized with endolysosomal markers within 90 min, suggesting that YF-VAX is processed rapidly in DCs. These results indicate that restricted virus replication and lysosomal compartmentalization may be important contributing factors to the success of the YF-VAX vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17170447     DOI: 10.1099/vir.0.82272-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

Review 1.  Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology.

Authors:  Bali Pulendran
Journal:  Nat Rev Immunol       Date:  2009-09-18       Impact factor: 53.106

2.  Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragment.

Authors:  Marlon G Veloso de Santana; Patrícia C C Neves; Juliana Ribeiro dos Santos; Noemia S Lima; Alexandre A C dos Santos; David I Watkins; Ricardo Galler; Myrna C Bonaldo
Journal:  Virology       Date:  2014-02-08       Impact factor: 3.616

3.  Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.

Authors:  Xiaohong Jiang; Tim J Dalebout; Peter J Bredenbeek; Ricardo Carrion; Kathleen Brasky; Jean Patterson; Marco Goicochea; Joseph Bryant; Maria S Salvato; Igor S Lukashevich
Journal:  Vaccine       Date:  2010-12-08       Impact factor: 3.641

Review 4.  Yellow fever: a reemerging threat.

Authors:  Christina L Gardner; Kate D Ryman
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

Review 5.  Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.

Authors:  Florian Douam; Alexander Ploss
Journal:  Trends Microbiol       Date:  2018-06-19       Impact factor: 17.079

6.  Yellow Fever Virus, but Not Zika Virus or Dengue Virus, Inhibits T-Cell Receptor-Mediated T-Cell Function by an RNA-Based Mechanism.

Authors:  James H McLinden; Nirjal Bhattarai; Jack T Stapleton; Qing Chang; Thomas M Kaufman; Suzanne L Cassel; Fayyaz S Sutterwala; Hillel Haim; Jon C Houtman; Jinhua Xiang
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226

7.  Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii.

Authors:  Cristina T Stoyanov; Silvia B Boscardin; Stephanie Deroubaix; Giovanna Barba-Spaeth; David Franco; Ruth S Nussenzweig; Michel Nussenzweig; Charles M Rice
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

8.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

9.  Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial.

Authors:  Anna H Roukens; Ann C Vossen; Peter J Bredenbeek; Jaap T van Dissel; Leo G Visser
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

10.  The Attenuated Live Yellow Fever Virus 17D Infects the Thymus and Induces Thymic Transcriptional Modifications of Immunomodulatory Genes in C57BL/6 and BALB/C Mice.

Authors:  Breno Luiz Melo-Lima; Danillo Lucas Alves Espósito; Benedito Antônio Lopes da Fonseca; Luiz Tadeu Moraes Figueiredo; Philippe Moreau; Eduardo Antonio Donadi
Journal:  Autoimmune Dis       Date:  2015-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.